Home›Companies›Healthcare›Meduloc

Meduloc, Inc.

Makes implants that surgeons use to stabilize broken bones.

Updated Nov 9, 2026·Latest SEC filing Aug 6, 2026·Suggest an edit

About Meduloc

Meduloc is a private company based in Del Mar, California. It has reported $5,843,496 raised in three offerings on Form D since March 2024. Its chief executive is Sarah Sachinis.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 24, 2026Aug 6, 2026$1,843,000fully sold2$921KEquity, OptionsRule 506(b)Form D ↗
Feb 6, 2026Feb 17, 2026$2,156,940fully sold11$196KEquity, OptionsRule 506(b)Form D ↗
Feb 21, 2024Mar 7, 2024$1,843,556fully sold10$184KEquity, OptionsRule 506(b)Form D ↗
Total, three offerings$5,843,496

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Meduloc's Form D filed Aug 6, 2026.

BA
KB
Kim Brady
Director
MC
Michael Collins
Director
Also a chief executive officer and director at Agilis Medical, a secretary, chief operating officer and director at Channel Robotics and a director at Sail Fusion.
RP
Renu Parker
Director
Also a director at Agilis Medical.
SS
Sarah Sachinis
CEO and President, director

Earlier filings also listed Joshua Huesdt (director, last listed Feb 2026), David Chersky (director, last listed Feb 2026), Bill Hagaman (director, last listed Feb 2026), Benjamin Arnold (executive officer and director, last listed Mar 2024) and Alyson Ronald (executive officer, last listed Mar 2024).

Sources

  1. SECMeduloc, Inc. filing history
  2. PressMeduloc FDA clearance announcement